Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,052 public trials 2,037 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma

NCT00008268

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00016172

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

PS-341 in Treating Patients With Hematologic Cancer

NCT00006098

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +46 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia

NCT00514696

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Rocky Mountain Cancer Centers Denver, Colorado, United States

Cancer Centers of Florida Winter Park, Florida, United States

Central Indiana Cancer Centers Indianapolis, Indiana, United States

Dayton Oncology & Hematology Kettering, Ohio, United States

View Trial Details

Completed

Effect of Interactive Tailored Assessment on Patient-provider Communication

NCT00857103

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Rikshospitalet University Hospital Oslo, Norway

View Trial Details

Completed

Diffuse Large B Cell Lymphoma of the Adult: Randomization Between High Dose Chemotherapy With Rituximab and CHOP 14-Rituximab

NCT00561379

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Nantes University Hospital Nantes, France

View Trial Details

Completed

Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

NCT00048737

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Screening for Coronary Artery Disease After Mediastinal Irradiation

NCT01271127

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +16 more
Locations: Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Completed

Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

NCT00002700

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Algemeen Ziekenhuis Middelheim Antwerp, Belgium

A.Z. St. Jan Bruges, Belgium

C.H.U. Saint-Pierre Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

View all 44 locations

View Trial Details

Completed

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

NCT00613665

Conditions: Digestive System Diseases, Digestive System Neoplasms, Duodenal Diseases, +20 more
Locations: Universitaetsklinikum Charité Berlin, Germany

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions